nice numbers in theory amd nice bait. go look at what impact new med device technology is making in India like tavr. uptake is low and concentrated in hands of only very small percentage of wealthy. its a
Ann: Regulatory approval to launch CardioCel in India, page-60
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.78 |
Change
0.780(8.67%) |
Mkt cap ! $206.7M | |||
| Open | High | Low | Value | Volume |
| $9.00 | $9.83 | $8.68 | $324.0K | 35.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 970 | $9.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.85 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |